$6.17
00.00%
Pre-Market: 4:20 PM EDT
Comments
Loading...
Adverum Biotechnologies (ADVM) Forecast
NewsEarningsAdverum Biotechnologies (ADVM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAdverum Biotechnologies (NASDAQ:ADVM) Stock Quotes, Forecast and News Summary
Adverum Biotechnologies Stock (NASDAQ: ADVM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Adverum Biotechnologies (ADVM) stock?
You can purchase shares of Adverum Biotechnologies (NASDAQ:ADVM) through any online brokerage.
Who are Adverum Biotechnologies (ADVM) competitors?
Other companies in Adverum Biotechnologies’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Invizyne Technologies (NASDAQ:IZTC).
What is the forecast, or price target, for Adverum Biotechnologies (ADVM) stock?
Adverum Biotechnologies has a consensus price target of $24.14.
What is the current price for Adverum Biotechnologies (ADVM)?
The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $6.17 last updated November 20, 2024 at 4:20 PM EST.
Does Adverum Biotechnologies (ADVM) pay a dividend?
There are no upcoming dividends for Adverum Biotechnologies.
When is Adverum Biotechnologies (NASDAQ:ADVM) reporting earnings?
Adverum Biotechnologies’s Q3 earnings are confirmed for Monday, November 4, 2024.
Is Adverum Biotechnologies (ADVM) going to split?
There is no upcoming split for Adverum Biotechnologies.
What sector and industry does Adverum Biotechnologies (ADVM) operate in?
Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.